Author

R. J. Cox

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Assay:proteomics· 4 Research Focus:drug response / drug discovery· 3 Organism:human· 3 Organism:mouse· 2 Approach:benchmark study· 1 Assay:imaging· 1

Frequent Co-Authors

F. Zhou· 3 shared A. Aasberg· 1 shared A. Barratt-Due· 1 shared A. Bergqvist· 1 shared A. Chopra· 1 shared A. Ianevski· 1 shared A. K. Anthi· 1 shared A. Kolderup· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

F. Zhou

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Prolonging the Delivery of Influenza Virus Vaccine Improves the Quantity and Quality of the Induced Immune Responses in Mice

M. Beukema, S. Gong, K. Al-Jaawni, J. J. de Vries-Idema, F. Krammer, F. Zhou, R. J. Cox, A. L. W. Huckriede

This study shows that prolonged influenza vaccine delivery in mice enhances both the quantity and quality of immune responses compared to prime-boost immunization.

bioRxiv · Aug 24, 2023 · PreprintImmunology

Evaluating the bioactivities of natural and synthetic fungal tropolone sesquiterpenoids in various cell lines

T. C. Bergmann, M. Menssen, C. Schotte, R. J. Cox, C. Lee-Thedieck

The paper evaluates the bioactivities of natural and synthetic fungal tropolone sesquiterpenoids in various cell lines, showing differential effects on metabolic activity and proliferation.

bioRxiv · Jul 19, 2023Cell Biology

Titers of antibodies the receptor-binding domain (RBD) of ancestral SARS-CoV-2 are predictive for levels of neutralizing antibodies to multiple variants

T. T. Tran, E. B. Vaage, A. Mehta, A. Chopra, A. Kolderup, A. K. Anthi, M. Konig, G. Nygard, A. Lind, F. Muller, L. S. H. Nissen-Meyer, P. Magnus, L.-I. S. Trogstad, S. Mjaaland, A. Soraas, , F. Lund-Johansen

This study shows that anti-RBDwt titers correlate with neutralizing antibody levels against multiple SARS-CoV-2 variants and proposes a method to improve immunomonitoring precision and throughput.

bioRxiv · Mar 26, 2022 · PreprintImmunology

A novel Pan-viral prophylaxis strategy using vaccine adjuvant CAF09b protects against influenza virus infection

J. Zimmermann, S. T. Schmidt, R. Trebbien, R. J. Cox, F. Zhou, F. Follmann, G. K. Pedersen, D. Christensen

This study shows that the adjuvant CAF09b can protect mice from influenza infection when administered before viral exposure but not after.

bioRxiv · Oct 21, 2021 · PreprintImmunology

Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis

K. Bosl, A. Ianevski, T. T. Than, P. I. Andersen, S. Kuivanen, M. Teppor, E. Zusinaite, U. Dumpis, A. Vitkauskiene, R. J. Cox, H. Kallio-Kokko, A. Bergqvist, T. Tenson, V. Oksenych, M. Bjoras, , R. K. Kandasamy

This study identifies critical host-virus interaction nodes through network analysis and drug re-purposing, revealing key targets for antiviral therapies.

bioRxiv · Feb 13, 2019 · PreprintImmunology